Diversity, Economic Growth and a Bug in the Research
Whether research shows benefits from diversity depends heavily on choice of study design
Across 145 Years and 17 Countries, a Common Thread in Risky Credit Booms
Do investors misprice assets, revise their risk appetite or make some other misjudgment?
Most Job Seekers Skip Negotiation — and Pay a High Price
Even in lucrative fields, candidates leave money on the table by taking the first offer
A Proposal To Improve Supplier Reliability in Tech Manufacturing
Withholding renewal of a supply agreement can be more powerful than other carrots and sticks
Boom of Intangible Assets Felt Across Industries and Economy
Rethinking issues around productivity, income inequality and industry concentration
How White Men, Discussing Race and Gender Inequities, Can Gain Credibility
Adding a note of personal advocacy to any factual statement helps a lot
All Alone in the Office? Take This Quiz
Alternative vaccination points, the curious case of improved sales forecasts and an overlooked stock-price predictor
Free Birth Control, Fewer Births
Unintended pregnancies decline when copays and patient fees are eliminated
A Nudge to Reduce the Government Tab for Nursing Home Care
An upfront fee for taking Medicaid patients could shorten stays
Proposed: Give Consumers on Amazon a Direct Line to Small Business Products
Third-party sellers would gain; consumers might pay more but increase control of products display
Passion for Work, Gender and Getting Promoted
Also, upheaval in the mortgage market, birth rates and emigration, and choice overload in shopping
Loan Pool Covenants, Meant to Contain Risk, Can Instead Spread It
Forced sale of assets could stretch illiquidity across industries
Graphic Presentation of COVID-19 Data Can Skew Perceptions of Risk
Showing cumulative cases — not day-to-day trends — could nudge people to avoid reckless behavior
Why Do Startups Make International Moves?
In connection with funding, typically; those chasing money abroad tend to raise a lot more of it
When Medicare Pays, Drug Companies Employ Older Subjects in Clinical Trials
The shift lends credibility to medicines vs. trials that exclude people 65 and older
Trump’s Tariffs Did, In Fact, Hurt U.S. Importers
Companies with Chinese suppliers suffered — those with more diversified supply chains suffered more